10/12/2026
🧬 What if CRISPR began not with bacteria defending themselves against viruses, but with viruses waging war against one another? In two remarkable papers published in Science September 17, 2026), Jennifer Doudna’s laboratory describes VIPR, an ancient RNA-guided DNA recognition system evolutionarily linked to Cas5 and the origins of CRISPR. But the implications may extend far beyond antiviral defense. Imagine harnessing this machinery to selectively silence or activate genes, or even reprogram epigenetic regulation, without cutting or permanently altering the human genome. Much more research is needed, but the possibilities are extraordinary. At TopoGEN, Inc., we are developing epigenetically silenced GFP reporter systems that provide a powerful means of visualizing changes in gene expression and screening for novel epigenetic therapeutics. We would argue that the next revolution in genetic medicine won't be about rewriting DNA—but learning how to control its expression. Doudna and coauthors make a particularly profound observation: "the discovery of a new code for RNA-mediated sequence recognition expands the known design space for programmable genetic control." Their findings suggest that entirely new mechanisms of RNA-guided genetic regulation may still await discovery. This is truly astounding.
\
